GUAVA TECHNOLOGIES ANNOUNCES NEW LINE OF ANTIBODY REAGENTS OPTIMIZED FOR GUAVA SYSTEMS

Guava Technologies, Inc., a leading developer of cost-effective and accessible cell-analysis systems for life science research, drug discovery, development and clinical diagnostics, today announced the introduction of Express Cell Surface Antibodies, a new line of antibody reagents designed to identify subsets of hematopoetic-derived cells by their patterns of protein expression. This is the first of several new reagent lines that Guava intends to introduce this year for use by life sciences researchers.
International News Service